FDAFDA · Food and drugs·Recall number D-0026-2019
Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30
Published October 17, 2018 · Recall initiated: September 10, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Takeda Development Center Americas, Inc.
- Distributor
- AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico
- Lot
- Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.